NVision Imaging Technologies

Hyperpolarised-MRI contrast agents via parahydrogen and NV-based polarisation transfer; POLARIS clinical-MRI platform deployed at Memorial Sloan Kettering, University of Cambridge, Technical University of Munich. Expanded 2026-05-13 into quantum computing with the PIQC (Photonic Integrated Quantum Circuits) platform integrating organic-molecule qubits onto photonic chips for drug-discovery applications. Series B closed 2026-05-13 ($55M + $17M EIB venture loan; cumulative $120M raised).